RNS Number:9858Q
GeneMedix PLC08 February 2007 8 February 2007 GeneMedix Plc Delay of cancellation of listing on the Official List and Admission to AIM
GeneMedix plc ("GeneMedix" or "the Company"), the UK biopharmaceutical company listed on the London and Singapore
Stock Exchanges, announces that, owing to a delay in satisfying completion requirements for the Proposal, it is now expected that the final day of trading of the Company's
shares on the Official List will be 15 February 2007 and that the Admission to AIM and consolidation of the Company's ordinary shares will take place on 16 February 2007.
ENQUIRIES:
GeneMedix plc Tel: 01638 663320
Julian Attfield, Chief Executive Officer
Bankside Consultants Tel: 020 7367 8888
Susan Scott / Daniela Hale This information is provided by RNS The company news service from the London Stock Exchange
END
MSCDVLFBDLBXBBK
For more information and to contact AFX: www.afxnews.com andwww.afxpress.com
Any information, prospectus or other document, or any hypertext link to any of the aforesaid should not be construed as advice on investments or a personal recommendation by ALL IPO plc and is being offered on an execution-only basis. Any decision to invest should be made only after careful consideration of the relevant documentation and particularly after acceptance of the full terms and conditions relating to the specific investment opportunity. Share prices, values and income can go down as well as up and you may get back less than the amount you invested. If in doubt about the suitability of investments referred to in this communication and on our website, you should consult an investment adviser authorised under the Financial Services and Markets Act 2000.
